Anti-Asthma Drugs Market Trends
That Will Drive Success In 2022
The report for Global Anti-Asthma Drugs Market of Market Research Future comprises extensive primary
research along with the detail analysis of qualitative as well as quantitative aspects by various industry
experts, key opinion leaders to gain the deeper insight of the market and industry performance.
Asthma is a chronic lung disease characterized by hyper responsiveness of tracheobronchial smooth muscle
to stimuli, resulting in narrowing and inflammation of air tubes, accompanied by increased secretion,
swelling and build-up of tissue fluid. Symptoms include tight chest, wheezing, cough and may be limitation
of activity due to difficulty in breathing.
Approximately, 300 million people suffer from asthma in 2015 and the figures are mounting which is blamed
on increased pollution and unhealthy lifestyles.
Global Anti-Asthma Drugs Market has been segmented on the basis of by type, trigger, therapy, drug class
and by route of administration. This has bloated the market to around USD 18.9 billion as of 2015 which is
expected to reach USD 28.3 billion as of 2022, resulting in a CAGR of 5.94%. The factors favoring the
growth of the market are growing awareness of the benefits of modern drug therapy, strong pipeline of anti-
asthma drugs with some novel molecules, growth in patients due to increasing pollution and great potential
of biologics which is anticipated to dominate the future market etc.
The constraining factors are loss of patents of leading brands, such as Advair and Symbicort, increasing
fragmentation of markets and generic penetration. It is heartening to note that we anticipate that the
growth factors will overwhelm the constraints and the market may take a strong growth due to
commercialization of the biologics segment.
Key Players for Global anti-asthma drugs market:
GlaxoSmithKline plc., Merck & Co., Inc., AstraZeneca plc., F. Hoffmann-La Roche Ltd, Teva Pharmaceutical
Industries, Novartis International AG, Boehringer Ingelheim, Sunovion Pharmaceuticals Inc.
Get Demo Copy @ https://www.marketresearchfuture.com/sample_request/2353 .
Regional Analysis of Global anti-asthma drugs market:
Globally North America is the largest market for anti-asthma drugs. Europe is the second-largest market for
anti-asthma drugs. The developing region especially Asia Pacific is accounting for major newer cases due to
greater screening and better health care facilities distribution. However the developing regions market
particularly Asia Pacific will be the fastest growing and will be the key to the future.
The report gives the clear picture of current market scenario which includes historical and projected market